255 related articles for article (PubMed ID: 8039304)
1. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S
J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364
[TBL] [Abstract][Full Text] [Related]
5. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.
Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K
Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980
[TBL] [Abstract][Full Text] [Related]
6. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
7. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
8. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.
Okada T; Li J; Kodaka M; Okuno H
Clin Exp Metastasis; 1998 Apr; 16(3):267-74. PubMed ID: 9568644
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.
Akai T; Niiya K; Sakuragawa N; Iizuka H; Endo S
J Neurooncol; 2002 Sep; 59(3):193-8. PubMed ID: 12241114
[TBL] [Abstract][Full Text] [Related]
12. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
[TBL] [Abstract][Full Text] [Related]
13. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
14. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
15. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
16. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.
Abdel Wahab N; Mason RM
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):777-83. PubMed ID: 9003362
[TBL] [Abstract][Full Text] [Related]
18. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Ree AH; Bjørnland K; Brünner N; Johansen HT; Pedersen KB; Aasen AO; Fodstad O
Clin Exp Metastasis; 1998 Apr; 16(3):205-15. PubMed ID: 9568638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
